Françoise Haramburu

4.0k total citations
129 papers, 2.7k citations indexed

About

Françoise Haramburu is a scholar working on Toxicology, Pharmacology and Geriatrics and Gerontology. According to data from OpenAlex, Françoise Haramburu has authored 129 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Toxicology, 27 papers in Pharmacology and 24 papers in Geriatrics and Gerontology. Recurrent topics in Françoise Haramburu's work include Pharmacovigilance and Adverse Drug Reactions (61 papers), Pharmaceutical Practices and Patient Outcomes (24 papers) and Drug-Induced Adverse Reactions (21 papers). Françoise Haramburu is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (61 papers), Pharmaceutical Practices and Patient Outcomes (24 papers) and Drug-Induced Adverse Reactions (21 papers). Françoise Haramburu collaborates with scholars based in France, Italy and New Zealand. Françoise Haramburu's co-authors include Bernard Bégaud, Ghada Miremont‐Salamé, Nicholas Moore, Annie Fourrier‐Réglat, Hélène Théophile, Alexandre Pariente, Bernard Bégaud, Yola Moride, Amélie Daveluy and Yannick Arimone and has published in prestigious journals such as Biometrics, Journal of Clinical Epidemiology and Statistics in Medicine.

In The Last Decade

Françoise Haramburu

125 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Françoise Haramburu France 30 1.5k 605 483 417 317 129 2.7k
Bernard Bégaud France 30 1.4k 1.0× 726 1.2× 525 1.1× 392 0.9× 240 0.8× 79 3.0k
Lorna Hazell United Kingdom 11 1.3k 0.9× 427 0.7× 640 1.3× 352 0.8× 183 0.6× 15 2.4k
Ghada Miremont‐Salamé France 22 801 0.5× 331 0.5× 279 0.6× 261 0.6× 138 0.4× 76 1.8k
Preciosa M. Coloma Netherlands 25 673 0.5× 227 0.4× 192 0.4× 138 0.3× 131 0.4× 46 1.9k
Raymond G. Schlienger Switzerland 34 379 0.3× 548 0.9× 526 1.1× 727 1.7× 203 0.6× 81 4.0k
François Montastruc France 29 406 0.3× 387 0.6× 261 0.5× 302 0.7× 211 0.7× 145 2.3k
Rosa Gini Italy 26 408 0.3× 149 0.2× 294 0.6× 118 0.3× 382 1.2× 123 2.3k
Stephan Lanes United States 29 383 0.3× 333 0.6× 174 0.4× 83 0.2× 252 0.8× 98 4.3k
Ju‐Young Shin South Korea 27 272 0.2× 254 0.4× 287 0.6× 303 0.7× 234 0.7× 303 3.0k
Xavier Kurz Netherlands 31 321 0.2× 390 0.6× 226 0.5× 86 0.2× 279 0.9× 92 3.5k

Countries citing papers authored by Françoise Haramburu

Since Specialization
Citations

This map shows the geographic impact of Françoise Haramburu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Françoise Haramburu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Françoise Haramburu more than expected).

Fields of papers citing papers by Françoise Haramburu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Françoise Haramburu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Françoise Haramburu. The network helps show where Françoise Haramburu may publish in the future.

Co-authorship network of co-authors of Françoise Haramburu

This figure shows the co-authorship network connecting the top 25 collaborators of Françoise Haramburu. A scholar is included among the top collaborators of Françoise Haramburu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Françoise Haramburu. Françoise Haramburu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Escolano, Sylvie, et al.. (2020). Identifying Drugs Inducing Prematurity by Mining Claims Data with High-Dimensional Confounder Score Strategies. Drug Safety. 43(6). 549–559. 4 indexed citations
2.
Bezin, Julien, Andy Smith, M Arnaud, et al.. (2017). Impact of Medicine Withdrawal on Reporting of Adverse Events Involving Therapeutic Alternatives: A Study from the French Spontaneous Reporting Database. Drug Safety. 40(11). 1099–1107. 6 indexed citations
3.
Daveluy, Amélie, Magali Labadie, Karine Titier, et al.. (2017). Poisoning by synthetic cathinones: Consumption behaviour and clinical description from 11 cases recorded by the Addictovigilance Centre of Bordeaux. Annales de Toxicologie Analytique. 29(1). 34–40. 6 indexed citations
4.
Daveluy, Amélie, et al.. (2016). Which psychoactive substances are used by patients seen in the healthcare system in French overseas territories? Results of the OPPIDUM survey. Fundamental and Clinical Pharmacology. 31(1). 126–131. 11 indexed citations
5.
Iaru, Irina, Ghada Miremont‐Salamé, Cristina Mogoșan, et al.. (2015). Preventability of adverse effects of analgesics: analysis of spontaneous reports. European Journal of Clinical Pharmacology. 71(5). 625–629. 9 indexed citations
6.
Pariente, Alexandre, Paul Avillach, Francesco Salvo, et al.. (2012). Effect of Competition Bias in Safety Signal Generation. Drug Safety. 35(10). 855–864. 59 indexed citations
7.
Daveluy, Amélie, Ghada Miremont‐Salamé, Catherine Lecomte, et al.. (2012). Identification of abuse and dependence cases through a hospital database. Pharmacoepidemiology and Drug Safety. 21(12). 1344–1349. 21 indexed citations
8.
Théophile, Hélène, Ghada Miremont‐Salamé, Philip Robinson, et al.. (2011). Relevance of a “Dear Doctor letter” to alert healthcare providers to new recommendations for vitamin D administration. European Journal of Clinical Pharmacology. 67(7). 681–686. 16 indexed citations
9.
Louët, Hervé Le, Elisabeth Loupi, Didier Guillemot, et al.. (2007). Which Pharmacovigilance for Vaccines?. Therapies. 62(3). 245–247. 3 indexed citations
10.
Louët, Hervé Le, Elisabeth Loupi, Didier Guillemot, et al.. (2007). Quelle pharmacovigilance pour les vaccins ?. Therapies. 62(3). 241–244. 2 indexed citations
11.
Pariente, Alexandre, et al.. (2007). Impact of Safety Alerts on Measures of Disproportionality in Spontaneous Reporting Databases. Drug Safety. 30(10). 891–898. 206 indexed citations
12.
Doussau, A., Frantz Thiessard, Ghada Miremont‐Salamé, C. Conri, & Françoise Haramburu. (2006). Effets indésirables psychiatriques des fluoroquinolones : cas notifiés à la pharmacovigilance française. La Revue de Médecine Interne. 27(6). 448–452. 12 indexed citations
13.
Molimard, Mathiéu, Abdelilah Abouelfath, A Fourrier, et al.. (2006). Insuffisance surrénalienne aiguë et hypercorticisme induits par des corticoïdes inhalés. Revue Française d Allergologie et d Immunologie Clinique. 46(6). 592–592. 1 indexed citations
14.
Olivier, Pascale, Jacques Caron, Françoise Haramburu, et al.. (2005). Validation d’une échelle de mesure : exemple de l’échelle française d’évitabilité des effets indésirables médicamenteux. Therapies. 60(1). 39–45. 32 indexed citations
15.
Arimone, Yannick, Bernard Bégaud, Ghada Miremont‐Salamé, et al.. (2005). Agreement of expert judgment in causality assessment of adverse drug reactions. European Journal of Clinical Pharmacology. 61(3). 169–173. 77 indexed citations
16.
Dumoulin, Chantale, et al.. (2005). Effectiveness and safety profile of leflunomide in rheumatoid arthritis: actual practice compared with clinical trials.. PubMed. 23(1). 80–4. 16 indexed citations
17.
Haramburu, Françoise, et al.. (2000). Incidence et prévalence des effets indésirables des médicaments.. La Presse Médicale. 29(2). 4 indexed citations
18.
Aguirre, C & Françoise Haramburu. (1996). [Official systems of pharmacovigilance in France and in Spain. Comparison of spontaneous reporting in two regional centers: Pays Basque and Bordeaux].. PubMed. 50(6). 563–9. 4 indexed citations
19.
Bégaud, Bernard, et al.. (1986). [Sensitivity and specificity of imputability criteria. Study and comparison of these efficacity indices for 7 methods].. PubMed. 40(5). 307–12. 8 indexed citations
20.
Bégaud, Bernard, et al.. (1985). [Drug surveillance as seen by the general practitioner. Apropos of a survey of 4175 physicians].. PubMed. 39(5). 453–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bernard Bégaud Breakdown of academic impact, for papers by Lorna Hazell Breakdown of academic impact, for papers by Ghada Miremont‐Salamé Breakdown of academic impact, for papers by Preciosa M. Coloma Breakdown of academic impact, for papers by Raymond G. Schlienger Breakdown of academic impact, for papers by François Montastruc Breakdown of academic impact, for papers by Rosa Gini Breakdown of academic impact, for papers by Stephan Lanes Breakdown of academic impact, for papers by Ju‐Young Shin Breakdown of academic impact, for papers by Xavier Kurz
Rankless by CCL
2026